6:53 AM ET
8-K
Investor Meeting
Cardinal Health Investor Meeting
Cardinal Health entered into a binding letter of intent to extend its pharmaceutical distribution agreements with CVS Health through June 2032. In connection with the extension, the company reaffirmed its fiscal year 2027 non-GAAP EPS guidance of $12.40 to $12.60 and its long-term growth targets.
- Counterparty
- CVS Health
- Term
- through June 2032